United States· US:50090-6636_b2a83c46-5a00-4fae-9541-4a33a36c69da
Losartan Potassium and Hydrochlorothiazide
A medicinal product containing losartan potassium; hydrochlorothiazide, registered in United States by A-S Medication Solutions.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11500906636090 TABLET, FILM COATED in 1 BOTTLE (50090-6636-0)
- ndc1150090-6636-0
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Losartan potassium; hydrochlorothiazide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLORISTA HKrka, d.d., Novo mesto, Novo mesto
- PolandHyzaar ForteOrganon Polska Sp. z o.o.
- United KingdomCozaar-Comp 100mg/12.5mg tabletsOrganon Pharma (UK) Ltd
- SpainCOZAAR PLUS 50 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAOrganon Salud S.L.
- FinlandAsolzidMylan AB
- ItalyFORZAARORGANON ITALIA S.R.L.
- FranceFORTZAAR 100 mg/12,5 mg, comprimé pelliculéORGANON FRANCE
- SwitzerlandCo-Losartan Sandoz
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cosaar, Losarcomp
- Belgium · Co-Losartan, Co-Losartan Teva
- Bulgaria · Ко-Хипертоник, Лозап H
- Cyprus · Losar Plus, Losartan/Hydrochlorothiazide Krka
- Czechia · Lorista H, Losartan/Hydrochlorothiazide Zentiva
- Germany · Fortzaar, Lorzaar Plus
- Denmark · Ancozan Comp, Cozaar Comp.
- Estonia · Lorista H, Lorista H 100/25 Mg
- Spain · Cozaar Plus, Fortzaar
- Finland · Cozaar Comp, Cozaar Comp Forte
- France · Fortzaar, Hyzaar
- United Kingdom (Northern Ireland) · Cozaar Comp, Losartan Potassium / Hydrochlorothiazide Generics (Uk)
- Greece · Co-Rabolan, Faxiven
- Croatia · Fortzaar, Hyzaar
- Hungary · Co-Arbartan, Hyzaar
- Ireland · Cozaar Comp, Losartan/Hydrochlorothiazide Clonmel
- Iceland · Cozaar Comp, Cozaar Comp Forte
- Italy · Forzaar, Hizaar
- Lithuania · Lorista H, Lozap H
- Luxembourg · Cozaar Plus, Cozaar Plus Forte
- Latvia · Lorista H
- Malta · Losartan/Hydrochlorothiazide Aurobindo
- Netherlands · Cozaar Plus, Entrizen/Hct
- Norway · Asolzid, Cozaar Comp
- Poland · Hyzaar, Hyzaar Forte
- Portugal · Cotiasar, Cozaar Plus
- Romania · Lorista H, Lorista Hl
- Sweden · Cozaar Comp, Cozaar Comp Forte
- Slovenia · Lorista H, Lorista Hd
- Slovakia · Lorista H, Losartan/Hydrochlorothiazid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dad477e9-6147-48fe-8cf0-a5171f668561 GET /v1/drugs/dad477e9-6147-48fe-8cf0-a5171f668561?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100; 25",
"substance": "LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE",
"productndc": "50090-6636",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA201845",
"marketing_category": "ANDA"
}See everything about losartan potassium; hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.